An Active Surveillance Study to Monitor the Real-World Safety of Ritlecitinib Among Patients with Alopecia Areata in Denmark, France, and Sweden First published 21/05/2025 Last updated 21/05/2025 EU PAS number:EUPAS1000000512 Study Planned